STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,739 | -70.4% | 3,741 | -20.1% | 0.00% | -100.0% |
| Q2 2023 | $49,780 | +138177.8% | 4,683 | +9.1% | 0.00% | +100.0% |
| Q1 2023 | $36 | -88.7% | 4,293 | -87.6% | 0.00% | -92.3% |
| Q4 2022 | $319 | -99.3% | 34,493 | +914.8% | 0.01% | +1200.0% |
| Q3 2022 | $44,000 | -30.2% | 3,399 | -28.8% | 0.00% | 0.0% |
| Q2 2022 | $63,000 | -66.8% | 4,775 | -47.3% | 0.00% | -50.0% |
| Q1 2022 | $190,000 | +153.3% | 9,060 | +189.0% | 0.00% | +100.0% |
| Q4 2021 | $75,000 | +87.5% | 3,135 | +100.2% | 0.00% | 0.0% |
| Q3 2021 | $40,000 | -84.3% | 1,566 | -79.2% | 0.00% | -85.7% |
| Q2 2021 | $254,000 | +323.3% | 7,535 | +385.2% | 0.01% | +600.0% |
| Q1 2021 | $60,000 | -51.6% | 1,553 | -22.3% | 0.00% | -75.0% |
| Q4 2020 | $124,000 | -49.0% | 1,999 | -72.4% | 0.00% | +33.3% |
| Q3 2020 | $243,000 | +117.0% | 7,231 | +53.7% | 0.00% | -40.0% |
| Q2 2020 | $112,000 | – | 4,704 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $9,991,000 | 2.07% |
| RTW INVESTMENTS, LP | 3,644,248 | $122,665,000 | 1.85% |
| Cormorant Asset Management, LP | 1,278,276 | $43,027,000 | 1.46% |
| Redmile Group, LLC | 2,458,558 | $82,755,000 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 233,135 | $7,847,000 | 0.53% |
| Birchview Capital, LP | 15,000 | $505,000 | 0.30% |
| Perceptive Advisors | 1,343,956 | $45,238,000 | 0.29% |
| GILDER GAGNON HOWE & CO LLC | 1,245,956 | $41,939,000 | 0.21% |
| Artal Group S.A. | 250,000 | $8,415,000 | 0.17% |
| Casdin Capital, LLC | 120,000 | $4,039,000 | 0.10% |